Sky Century Investment (SKYI) Enterprise Value (2012 - 2026)
Sky Century Investment's (SKYI) quarterly Enterprise Value came in at -$264.0 in Q2 2026, up 97.67% year-on-year from -$133.56 in Q2 2025, and up 92.14% on a QoQ basis from -$3360.0 in Q1 2026.
Sky Century Investment (SKYI) Enterprise Value (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 5 years of Enterprise Value data on file, last reported at -$264.0 in Q2 2026.
- On a quarterly basis, Enterprise Value rose 97.67% year-over-year to -$264.0 in Q2 2026; TTM through May 2026 was -$264.0, a 97.67% increase from a year earlier, with the FY2025 full-year figure at -$477.0, changed N/A from the prior year.
- Enterprise Value for Q2 2026 stood at -$264.0, up from -$3360.0 in the prior quarter.
- Over the last five years, Enterprise Value for SKYI reached as high as -$264.0 in Q2 2026 and fell as low as -$11312.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | -264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -264.00 |
| Feb 28, 2026 | -3,360.00 |
| Nov 30, 2025 | -467.00 |
| Aug 31, 2025 | -477.00 |
| May 31, 2025 | -11,312.00 |
| Aug 31, 2014 | -515.00 |
| May 31, 2014 | -515.00 |
| Feb 28, 2014 | -515.00 |
| Nov 30, 2013 | -5,565.00 |
| Aug 31, 2013 | -479.00 |
| May 31, 2013 | -154.00 |
| Feb 28, 2013 | -154.00 |
| Aug 31, 2012 | -854.00 |